Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Kristen E. Battiato"'
Autor:
Mariely Nivar, Isaac Deonarine, Liana Butala, David A. Knorr, Jessica Lunkenheimer, Saumya Sharan, Anthony R. Mato, Kristen E. Battiato, Lindsey E. Roeker, Carissa Laudati, Nicole Peters, Sonia Lebowitz, Meghan C. Thompson, Angela Richford, Vanessa Chanlatte, Saddia Momotaj, Bianca Hampton, Lindsay Amato
Publikováno v:
Leukemia. 35(9)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6a9706d37bff3b4d24397687a46f2f67
https://pubmed.ncbi.nlm.nih.gov/33986431
https://pubmed.ncbi.nlm.nih.gov/33986431
Autor:
Bita Fakhri, Catherine C. Coombs, John M. Pagel, Lindsey E. Roeker, Joanna M Rhodes, Kendall Meyer, Anthony R. Mato, Jeffrey L. Jensen, Paola Ghione, Neil Bailey, Toby A. Eyre, Meghan C. Thompson, Yehudit Fox, Kristen E. Battiato
Publikováno v:
Blood. 138:2629-2629
Background: Non-covalent Bruton's Tyrosine Kinase inhibitors (ncBTKi) are in clinical development for the treatment of chronic lymphocytic leukemia (CLL) and Richter Transformation (RT). These agents (pirtobrutinib, ARQ-531, SNS-062) reversibly bind
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::3af78ec057410b729a61dfd7a700b483
https://doi.org/10.1182/blood-2021-148592
https://doi.org/10.1182/blood-2021-148592
Autor:
Kristen E. Battiato, Hari P. Miskin, Gail Panton, Camila Pena-Velasquez, Yehudit Fox, Victoria Falco, Rosalba Martignetti, Sabrina Kdiry, Lori A. Leslie, Elizabeth L. McCarthy, Lindsey E. Roeker, Carissa Laudati, Andrew D. Zelenetz, Jae H. Park, Sonia Lebowitz, Anthony R. Mato, Meghan C. Thompson, Lorenzo Falchi, Peter Sportelli, Jake D. Soumerai, David J. Straus
Publikováno v:
Blood. 138:395-395
Background: While time-limited novel agent combinations have demonstrated high overall response rates and durable responses for patients with chronic lymphocytic leukemia (CLL), they also have high rates of adverse events and possibly overtreat many
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::cfdbc6ce69bcf6964d1d31afce0cb006
https://doi.org/10.1182/blood-2021-146999
https://doi.org/10.1182/blood-2021-146999
Autor:
Paul M. Barr, Nicole Lamanna, Paola Ghione, Craig A. Portell, Stephen J. Schuster, Ryan Jacobs, Javier Pinilla-Ibarz, Lindsey E. Roeker, Andrew D. Zelenetz, Neil Bailey, Celina J. Komari, Brian T. Hill, Alan P Skarbnik, Danielle M. Brander, John M. Pagel, Chaitra S. Ujjani, Anthony R. Mato, Kristen E. Battiato, Toby A. Eyre, John N. Allan, Joanna M Rhodes, Mazyar Shadman, Julia H. Aronson, Manali Kamdar, Guilherme Sacchi De Camargo Correia, Jeffrey L. Jensen, Meghan C. Thompson, Bita Fakhri, Catherine C. Coombs, Jeffrey J. Pu
Publikováno v:
Blood. 138:2628-2628
Background: Targeted therapies including ibrutinib, acalabrutinib and venetoclax (ven) have fundamentally changed the treatment of patients (pts) with chronic lymphocytic leukemia (CLL) leading to improved outcomes and durable remissions for many pts
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5c9641956ec555e416539c38af60d4ba
https://doi.org/10.1182/blood-2021-150751
https://doi.org/10.1182/blood-2021-150751
Autor:
Isaac Deonarine, M. Sarraf Yazdy, Colleen Dorsey, Bruce D. Cheson, Hannah Morse, Joseph R. Carver, Anthony R. Mato, Lindsey E. Roeker, Mayur Narkhede, Kristen E. Battiato, Kaitlin Kennard, Julie Goodfriend, L. Gashonia, Joanna Rhodes, Stephen J. Schuster
Publikováno v:
Hematological Oncology. 37:212-213
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d0e57772e5c1e168546b3a33988c8712
https://doi.org/10.1002/hon.28_2630
https://doi.org/10.1002/hon.28_2630
Autor:
Hannah Morse, Stephen J. Schuster, M. Peterson, Anthony R. Mato, B. Cheson, Julie Goodfriend, Joseph R. Carver, Lindsey E. Roeker, Mayur Narkhede, M Yazdy, Colleen Dorsey, Joanna Rhodes, Kristen E. Battiato, Kaitlin Kennard, L. Gashonia
Publikováno v:
HemaSphere. 3:145
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1157e6d8ad5ac0fbccad550a36579553
https://doi.org/10.1097/01.hs9.0000559756.43817.f1
https://doi.org/10.1097/01.hs9.0000559756.43817.f1